A World Without Infectious Disease

Help Make Covid-19 History

The COMET-ICE study is now enrolling qualifying adults with mild-to-moderate COVID-19

If you’ve been experiencing mild-to-moderate symptoms of COVID-19 within the last 2–3 days, and you are at high risk of severe disease, you may be able to play an important role in the fight against this global pandemic.

Researchers are studying the effectiveness of an investigational medication designed to prevent COVID-19 disease from becoming more severe. By participating in this study, you may have a lasting impact on your community, your country and the world.

To learn more about the study and determine whether you are eligible to participate, please visit www.makecovid19history.com.